ALT
Price
$7.91
Change
-$0.49 (-5.83%)
Updated
Dec 18, 04:29 PM (EDT)
99 days until earnings call
RIGL
Price
$17.18
Change
-$1.27 (-6.88%)
Updated
Dec 18, 04:27 PM (EDT)
Ad is loading...

ALT vs RIGL

Header iconALT vs RIGL Comparison
Open Charts ALT vs RIGLBanner chart's image
Altimmune
Price$7.91
Change-$0.49 (-5.83%)
Volume$5.25K
CapitalizationN/A
Rigel Pharmaceuticals
Price$17.18
Change-$1.27 (-6.88%)
Volume$700
CapitalizationN/A
ALT vs RIGL Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. RIGL commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and RIGL is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ALT: $8.40 vs. RIGL: $18.45)
Brand notoriety: ALT and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 84% vs. RIGL: 62%
Market capitalization -- ALT: $640.12M vs. RIGL: $325M
ALT [@Biotechnology] is valued at $640.12M. RIGL’s [@Biotechnology] market capitalization is $325M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALT and RIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 5 bearish.
  • RIGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а -6.77% price change this week, while RIGL (@Biotechnology) price change was -10.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.08%. For the same industry, the average monthly price growth was -1.25%, and the average quarterly price growth was +1.32%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-6.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($640M) has a higher market cap than RIGL($325M). RIGL YTD gains are higher at: 27.241 vs. ALT (-25.333). RIGL has higher annual earnings (EBITDA): 13.7M vs. ALT (-103.19M). ALT has more cash in the bank: 139M vs. RIGL (61.1M). ALT has less debt than RIGL: ALT (1.77M) vs RIGL (60.2M). RIGL has higher revenues than ALT: RIGL (157M) vs ALT (52K).
ALTRIGLALT / RIGL
Capitalization640M325M197%
EBITDA-103.19M13.7M-753%
Gain YTD-25.33327.241-93%
P/E RatioN/A68.33-
Revenue52K157M0%
Total Cash139M61.1M227%
Total Debt1.77M60.2M3%
FUNDAMENTALS RATINGS
ALT vs RIGL: Fundamental Ratings
ALT
RIGL
OUTLOOK RATING
1..100
6255
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3939
P/E GROWTH RATING
1..100
10090
SEASONALITY SCORE
1..100
5033

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RIGL's Valuation (88) in the Biotechnology industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that RIGL’s stock grew similarly to ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (75) in the Miscellaneous Commercial Services industry is in the same range as RIGL (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RIGL’s over the last 12 months.

ALT's SMR Rating (98) in the Miscellaneous Commercial Services industry is in the same range as RIGL (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RIGL’s over the last 12 months.

ALT's Price Growth Rating (39) in the Miscellaneous Commercial Services industry is in the same range as RIGL (39) in the Biotechnology industry. This means that ALT’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's P/E Growth Rating (90) in the Biotechnology industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that RIGL’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTRIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 27 days ago
85%
Bullish Trend 22 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTLVX22.00N/A
N/A
Wilshire Large Company Value Invmt
ITHVX57.10-0.33
-0.57%
Hartford Capital Appreciation R6
ERSTX25.92-0.15
-0.58%
Eaton Vance Large-Cap Value R
OFALX18.44-0.15
-0.81%
Olstein All Cap Value C
RYAHX139.15-2.49
-1.76%
Rydex Mid-Cap 1.5x Strategy A

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with RCUS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-3.61%
RCUS - RIGL
38%
Loosely correlated
-2.60%
NTLA - RIGL
37%
Loosely correlated
-1.87%
AGIO - RIGL
37%
Loosely correlated
-1.71%
WVE - RIGL
36%
Loosely correlated
+7.43%
ALT - RIGL
35%
Loosely correlated
-6.67%
More